Presentation is loading. Please wait.

Presentation is loading. Please wait.

Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas  Debra Nana Yeboa, James B. Yu,

Published byΚορνήλιος Κομνηνός Modified over 5 years ago

Similar presentations

Presentation on theme: "Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas  Debra Nana Yeboa, James B. Yu,"— Presentation transcript:

1 Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas  Debra Nana Yeboa, James B. Yu, Eric Liao, Jason Huse, Marta Penas-Prado, Benjamin H. Kann, Erik Sulman, David Grosshans, Joseph Contessa  Clinical and Translational Radiation Oncology  Volume 15, Pages (February 2019) DOI: /j.ctro Copyright © 2019 The Authors Terms and Conditions

2 Fig. 1 Study cohort consort diagram.
Clinical and Translational Radiation Oncology  , 46-52DOI: ( /j.ctro ) Copyright © 2019 The Authors Terms and Conditions

3 Fig. 2 Overall survival (OS) of patients with 1p19q co-deleted gliomas by tumor grade with Kaplan Meier OS estimates for the study and propensity score matched cohort. Clinical and Translational Radiation Oncology  , 46-52DOI: ( /j.ctro ) Copyright © 2019 The Authors Terms and Conditions

Download ppt "Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas  Debra Nana Yeboa, James B. Yu,"

Similar presentations

Outcomes of Induction Chemotherapy Plus Intensity-Modulated Radiotherapy (IMRT) Versus IMRT Plus Concurrent Chemotherapy for Locoregionally Advanced.

Outcomes of Induction Chemotherapy Plus Intensity-Modulated Radiotherapy (IMRT) Versus IMRT Plus Concurrent Chemotherapy for Locoregionally Advanced.
The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study  Ying Li, Sheng Zhang, Xi.

The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study  Ying Li, Sheng Zhang, Xi.
Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity  Sarah J. Stephens, MD, Samantha Thomas, MB,

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity  Sarah J. Stephens, MD, Samantha Thomas, MB,
Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.
The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis  K.

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis  K.
Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced.

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced.
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Volume 74, Issue 2, Pages (August 2018)

Volume 74, Issue 2, Pages (August 2018)
Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With.

Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With.
Volume 72, Issue 5, Pages (November 2017)

Volume 72, Issue 5, Pages (November 2017)
Differences in Performance Status Assessment Among Palliative Care Specialists, Nurses, and Medical Oncologists  Yu Jung Kim, MD, PhD, David Hui, MD,

Differences in Performance Status Assessment Among Palliative Care Specialists, Nurses, and Medical Oncologists  Yu Jung Kim, MD, PhD, David Hui, MD,
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.
Phase II Trial with Carboplatin and Bendamustine in Patients with Extensive Stage Small-Cell Lung Cancer  Wolf Köster, MD, Andrea Heider, MD, Norbert.

Phase II Trial with Carboplatin and Bendamustine in Patients with Extensive Stage Small-Cell Lung Cancer  Wolf Köster, MD, Andrea Heider, MD, Norbert.
Candida glabrata fungaemia in intensive care units

Candida glabrata fungaemia in intensive care units
Association Between the Volume of Inpatient Rehabilitation Therapy and the Risk of All- Cause and Cardiovascular Mortality in Patients With Ischemic Stroke 

Association Between the Volume of Inpatient Rehabilitation Therapy and the Risk of All- Cause and Cardiovascular Mortality in Patients With Ischemic Stroke 
Comparison of Patterns and Outcomes of Liver Resection for Hepatocellular Carcinoma: East vs West  Tian Yang, Parissa Tabrizian, Han Zhang, Wan-Yee Lau,

Comparison of Patterns and Outcomes of Liver Resection for Hepatocellular Carcinoma: East vs West  Tian Yang, Parissa Tabrizian, Han Zhang, Wan-Yee Lau,
Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S
A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients.

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients.
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database  Alex.

Similar presentations

Ads by Google